Spiperone enhances intracellular calcium level and inhibits the Wnt signaling pathway

22Citations
Citations of this article
26Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Wnt signaling affects fundamental development pathways by regulating cell proliferation and differentiation. Aberrant activation of Wnt/β-catenin signaling promotes the development of several cancers and is an attractive target for chemopreventive and chemotherapeutic agents. Results: In order to identify the novel antagonists for the Wnt/β-catenin pathway, we employed a cell-based Wnt reporter system (TOPflash) to screen a library of 960 known drugs. We identified spiperone, a psychotropic drug, as a novel Wnt inhibitor, which specifically blocks canonical Wnt signaling prior to the activation of β-catenin. The Wnt inhibitory function of spiperone is not associated with its dopamine-, serotonin- and sigma-receptor antagonist properties. Instead, spiperone increases intracellular calcium levels in a similar manner to thapsigargin, that also impedes Wnt signal transduction. Inhibition of protein kinase C had no effect on spiperone-mediated antagonism of Wnt signaling. Conclusion: Spiperone is a calcium regulator. It inhibits Wnt signaling by enhancing intracellular calcium levels. © 2009 Lu and Carson; licensee BioMed Central Ltd.

Cite

CITATION STYLE

APA

Lu, D., & Carson, D. A. (2009). Spiperone enhances intracellular calcium level and inhibits the Wnt signaling pathway. BMC Pharmacology, 9. https://doi.org/10.1186/1471-2210-9-13

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free